147 related articles for article (PubMed ID: 34161610)
1. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
3. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
7. Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
Crown A; Muhsen S; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2022 Sep; 29(9):5786-5796. PubMed ID: 35672625
[TBL] [Abstract][Full Text] [Related]
8. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
JAMA Oncol; 2021 Jan; 7(1):86-91. PubMed ID: 33211089
[TBL] [Abstract][Full Text] [Related]
9. Value of early referral to fertility preservation in young women with breast cancer.
Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
11. Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation.
Hill KA; Nadler T; Mandel R; Burlein-Hall S; Librach C; Glass K; Warner E
Clin Breast Cancer; 2012 Apr; 12(2):127-32. PubMed ID: 22444719
[TBL] [Abstract][Full Text] [Related]
12. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
13. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
[TBL] [Abstract][Full Text] [Related]
14. Fertility preservation for cancer patients: treatment gaps and considerations in patients' choices.
Kappy M; Lieman HJ; Pollack S; Buyuk E
Arch Gynecol Obstet; 2021 Jun; 303(6):1617-1623. PubMed ID: 33544203
[TBL] [Abstract][Full Text] [Related]
15. Does a dedicated program for young breast cancer patients affect the likelihood of fertility preservation discussion and referral?
Srikanthan A; Amir E; Warner E
Breast; 2016 Jun; 27():22-6. PubMed ID: 27212696
[TBL] [Abstract][Full Text] [Related]
16. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
[TBL] [Abstract][Full Text] [Related]
17. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Lawson AK; Smith KN; Kazer RR; Klock SC; Gradishar WJ; Jeruss JS; Pavone ME
Breast Cancer Res Treat; 2021 Apr; 186(2):429-437. PubMed ID: 33392838
[TBL] [Abstract][Full Text] [Related]
18. Fertility counselling and fertility preservation among early onset female cancer patients-A Finnish register-based study.
Melin J; Holopainen E; Savolainen-Peltonen H
Cancer Med; 2024 Feb; 13(3):e7034. PubMed ID: 38400669
[TBL] [Abstract][Full Text] [Related]
19. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study.
Duraes M; Rathat G; Bringer-Deutsch S; Ranisavljevic N; Brouillet S; Defez-Fougeron C; Duflos C
Breast; 2022 Aug; 64():121-126. PubMed ID: 35661841
[TBL] [Abstract][Full Text] [Related]
20. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
